Rallybio
RLYB
38 hedge funds and large institutions have $260M invested in Rallybio in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 2 closing their positions.
275% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 4
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
12% more funds holding
Funds holding: 34 → 38 (+4)
1.31% more ownership
Funds ownership: 9.36% → 10.67% (+1.3%)
38% less capital invested
Capital invested by funds: $420M → $260M (-$160M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIIC
AJU IB Investment Company
Seoul,
South Korea
|
+$11M |
| 2 |
JP Morgan Chase
New York
|
+$3.97M |
| 3 |
BlackRock
New York
|
+$2.75M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$641K |
| 5 |
State Street
Boston,
Massachusetts
|
+$353K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.29M |
| 2 |
Millennium Management
New York
|
-$1.08M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.03M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$176K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$6.75K |
RLYB Hedge Fund Activity: Q4 2021 in Review
38 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q4 2021, worth a combined $260M — down 38% from $420M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new RLYB positions and 2 closed out — a net gain of 5 holders — while 15 added to existing stakes and 4 trimmed.
The largest buyer was AJU IB Investment Company, opening a new position worth an estimated $11M. The largest seller was Sectoral Asset Management, cutting an estimated $3.29M.
- 38 institutional investors held Rallybio (RLYB) as of Q4 2021, up from 34 in Q3 2021.
- Funds reported $260M of Rallybio stock for Q4 2021, down 38% quarter-over-quarter.
- 7 funds opened new Rallybio positions in Q4 2021 and 2 closed out, a net change of +5 holders.
- The largest Rallybio buyer in Q4 2021 was AJU IB Investment Company, an estimated $11M added.
- The largest Rallybio seller in Q4 2021 was Sectoral Asset Management, an estimated $3.29M sold.
Based on aggregated 13F filings for Q4 2021.